General Western Blot Reagents
Abcam Doceta x el, Cytoto x ic agent, 50MG
MW 807.9 Da, Purity >99%. Potent cytotoxic agent in vitro (IC₅₀ = 2 nM). Disrupts microtubule assembly and arrests cell divison at G₂/M phase. Induces apoptosis. Antitumor agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Gabapentin, alpha2delta Ligand, 50MG
MW 171.24 Da, Purity >99%. Interacts with the α2δ subunit of L-type voltage gated Ca²+ channels. Disrupts calcium channel trafficking. Anticonvuslant and analgesic in vivo. Also available in simple stock solutions (ab146685) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clioquinol, Metal chelator and ionophore, 1G
MW 305.5 Da, Purity >97%. Metal chelator and ionophore with beneficial effects in animal models of neurodegenerative diseases (Alzheimer's, Parkinson's and Huntington's disease). Effects on Alzheimer's disease attributed to copper and zinc chelation or increased level of a metalloprotease. Other actions reported including iron chelation, inhibition of Huntington expression from its mRNA, proteasome inhibition when complexed with copper, and stimulation of tumor necrosis factor-α secretion. Also inhibitor of CLK-1/MCLK1 (an aging-associated protein).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Saclofen, GABAB antagonist, 50MG
MW 249.72 Da, Purity >98%. GABAB antagonist Also available in simple stock solutions (ab146704) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Lysolipin I, antibiotic agent.
Lysolipin I, antibiotic agent.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical StearIc AcId glycIdyl STRd 1mg
A C-21 steroid with anticancer activity cytotoxic to SMMC-7721 MCF-7 and HeLa cells (IC50s 24 95 65 82 and 247 54 UM respectively) induces apoptosis in and inhibits mammosphere formation by MDA-MB-231 breast cancer cells as well as decreases the number of CSCs in the MDA-MB-231 cell population from 50-300 UM reduces tumor volume in an MDA-MB-231 mouse xenograft model at 10 mg/kg
Abcam Atropine, mAChR antagonist, 1G
MW 289.4 Da, Purity >98%. Potent, competitive, non-selective mAChR antagonist (IC₅₀ = 2.5 nM). Induces mydriasis. Shows antimuscarinic and anticholinergic effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SBD-F (7-Fluorobenzofurazan-4-sulfonic acid ammonium salt), Fluorescent thiol indicator, 250MG
MW 235.2 Da, Purity >98%. Fluorescent thiol indicator. Reacts with sulfhydryl groups to produce highly fluorescent compounds. Attains low detection limits.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SBD-F (7-Fluorobenzofurazan-4-sulfonic acid ammonium salt), Fluorescent thiol indicator, 5MG
MW 235.2 Da, Purity >98%. Fluorescent thiol indicator. Reacts with sulfhydryl groups to produce highly fluorescent compounds. Attains low detection limits.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 3-Indole acetic acid (IAA), Natural phytohormone, 25G
MW 175.19 g/mol, Purity >99%. Natural phytohormone (plant auxin), synthesized from tryptophan, which induces plant cell elongation and division causing uncontrolled growth. Signaling molecule involved in plant organogenesis and growth control. Used as a supplement in media such as Murashige and Skoog media and Gamborg's B5 media.
The product is subject to the following: Abcam Restricted Use Statement
Abcam alpha-Calcitonin Gene Related Peptide (human), CGRP agonist, 500UG
MW 3789.3 Da, Purity >95%. alpha-Calcitonin Gene Related Peptide (human), CGRP agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement